Riskpilot← Back to searchSign inGet full accessPharmadule Emtunga AB
ABBankruptOrg 5566515598Rental and operating of own or leased real estate · NACE 6820Est. 2003324 employees
Revenue 2007
SEK 617,7M
-34% vs 2006
EBITDA margin
-23.1%
+42% vs 2006
Equity ratio
9.7%
Financial strength
Net profit 2007
SEK -172,2M
+35% vs 2006
| Revenue | SEK 617,7M | -34% |
| EBITDA | SEK -142,4M | +42% |
| Net profit | SEK -172,2M | +35% |
| Total assets | SEK 1,2B | -16% |
| Equity | SEK 120,4M | +78% |
| Employees | 324 | — |
Legal name
Pharmadule Emtunga AB
Org number
5566515598
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
10 november 2003
Share capital
SEK 6 468 000
Employees
324 (FTE)
VAT registered
No
Audit selected
No
Last report
2007-12-31
Financial year
January – December
Signatory rights
Uppgift om firmateckning saknasRegistrerad styrelse saknas. Registrerad kvalificerad revisor saknas. Registrerad styrelseordförande saknas.
Company purpose
Bolaget skall direkt eller genom hel- eller delägda bolag bedriva näringsverksamhet inom områdena tillverkning och marknadsföring av modulbyggda anläggningar för tillverkning av läkemedel, modulbyggda anläggningar till olje- och gasindustrin, enheter för mobila telefonsystem och andra tekniska system samt inom ramen för denna förvärva, äga, förvalta och försälja aktier, andelar, värdepapper, värdepappersrelaterade instrument, företag eller del därav samt förvalta och försälja fastigheter för egen räkning och ävensom bedriva därmed jämförlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2004 | 2005 | 2006 | 2007 |
|---|---|---|---|---|
| Revenue | 480 | 1 449 038 | 933 127 | 617 702 |
| Staff expenses | — | — | — | — |
| EBITDA | −2 774 | 62 883 | −246 684 | −142 449 |
| Depreciation & amort. | — | — | — | — |
| EBIT | −2 774 | 62 883 | −246 684 | −142 449 |
| Net financials | −34 610 | −70 410 | −93 907 | −77 266 |
| Profit before tax | −37 384 | −16 726 | −340 290 | −210 919 |
| Tax | 10 468 | −14 242 | 74 399 | 38 768 |
| Net profit | −26 916 | −30 968 | −265 891 | −172 151 |
| Item | 2004 | 2005 | 2006 | 2007 |
|---|---|---|---|---|
| Total assets | 1 692 055 | 1 710 035 | 1 483 951 | 1 241 403 |
| Equity | 93 943 | 133 616 | 67 725 | 120 413 |
| Long-term debt | 1 127 926 | 914 535 | 771 110 | 706 342 |
| Short-term debt | 470 186 | 612 572 | 596 105 | 374 433 |
| Total debt | 1 598 112 | 1 527 107 | 1 367 215 | 1 080 775 |
EBITDA margin
-23.1%
This company
15.8%
Market median
-246% vs market
20042007
Equity ratio
9.7%
This company
38.2%
Market median
-75% vs market
20042007
Return on equity
-143.0%
This company
18.4%
Market median
-877% vs market
20042007
Net profit margin
-27.9%
This company
8.1%
Market median
-444% vs market
20042007
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20042007
Debt / equity
9.31×
This company
0.62×
Market median
-1402% vs market
20042007
- Annual report 2007Filed via Bolagsverket / SCB · Period 2007-01-01 – 2007-12-31
- Annual report 2006Filed via Bolagsverket / SCB · Period 2006-01-01 – 2006-12-31
- Annual report 2005Filed via Bolagsverket / SCB · Period 2005-01-01 – 2005-12-31
- Annual report 2004Filed via Bolagsverket / SCB · Period 2003-11-01 – 2004-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmadule Emtunga AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gunnar Svennered | Board of Directors | 0 companies |